Archive/Reply to Ståhl et al. Comment on “Honndorf et al. Comparative Analytics and Pharmacodynamics of the Complex Protein-Free Botulinum Toxin Type A Formulations DaxibotulinumtoxinA, IncobotulinumtoxinA and RelabotulinumtoxinA. Toxins 2026, 18, 142”
Reply to Ståhl et al. Comment on “Honndorf et al. Comparative Analytics and Pharmacodynamics of the Complex Protein-Free Botulinum Toxin Type A Formulations DaxibotulinumtoxinA, IncobotulinumtoxinA and RelabotulinumtoxinA. Toxins 2026, 18, 142”
Stefanie Honndorf, Katja Kühbach, Karl-Heinz Eisele et al.
3 juillet 2026
en
Abstract
We appreciate the comment [...]
IPC Classification
A61
Keywords
replycommenthonndorfcomparativeanalyticspharmacodynamicscomplexprotein-freebotulinumtoxintypeformulationsdaxibotulinumtoxinaincobotulinumtoxinarelabotulinumtoxinatoxins2026appreciate
Citer cette publication
€ 4.00